Kesimpta ofatumumab 20 mg 1 syringe pen Syringe pen Новартис A new development for multiple sclerosis. \r\n Dosage: 20 mg subcutaneously once a month. 
Kesimpta, Bonspri ( ofatumumab) 20 mg in syringe-pen, Novartis
In Stock
A new development for multiple sclerosis.
Dosage: 20 mg subcutaneously once a month.
- Commercial name:Kesimpta
- Сhemical name:ofatumumab
- Dosage:20 mg
- Quantity:1 syringe pen
- Release form:Syringe pen
- Виробник:Новартис
No reviews yet